Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

POLYSAN Scientific & Technological Pharmaceutical Company

Home Clinical Trial Sponsors and OrganizationsPOLYSAN Scientific & Technological Pharmaceutical Company

POLYSAN Scientific & Technological Pharmaceutical Company

ACTIVE

Private

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

23

0 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 3

7

30.4%

Phase 2

5

21.7%

Phase 1

1

4.3%

Trial Status Distribution

Completed

18

78.3%

Recruiting

4

17.4%

Terminated

1

4.3%

Clinical Trials

Trials sponsored by this organization (23)

REAMBERIN® 1.5% in Rehydration Therapy of Diabetic Ketoacidosis

May 2025312 participants

Trial of the Efficacy and Safety of Use of Drug Product Reamberin® for Pathogenetic Therapy of Viral Enteric Infection in Children Aged 1-6 Years Old

Aug 2024300 participants

Evaluation of the Efficacy of Permanent Course Combined Therapy With CYTOFLAVIN® Intravenous Solution and CYTOFLAVIN Tablets, at 2-3 Stages of Rehabilitation of Patients With Post Intensive Care Syndrome

Mar 202490 participants

Observational Study of Efficiency of Cytoflavin, in Patients With Ischemic Stroke Not Receiving Reperfusion Therapy

Mar 2024562 participants

Study of Safety and Efficacy of the Drug Cycloferone in Patients with Acute Respiratory Viral Infection

Sep 2023742 participants

Cycloferon for Post-exposure Prophylaxis of Acute Respiratory Viral Infections and Influenza

Sep 2023166 participants

Cytoflavin in the Complex Rehabilitation of Stroke Patients

Jun 2023240 participants

Comparative Study of REMAXA®, Enteric-coated Tablets and REMAXOL®, Solution for Infusions, in Intrahepatic Cholestasis

May 2023328 participants

Page 1 of 3

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials23
Approvals
News

Back to Organizations